Results 41 to 50 of about 1,359 (148)

Neurofilament light chain and profilin‐1 dynamics in 30 spinal muscular atrophy type 3 patients treated with nusinersen

open access: yesEuropean Journal of Neurology, Volume 31, Issue 10, October 2024.
Abstract Background and Purpose The aim was to investigate whether neurofilament light chain (NfL) and profilin‐1 (PFN‐1) might qualify as surrogate disease and treatment‐response biomarkers by correlating their concentrations dynamic with clinical status in a cohort of 30 adult spinal muscular atrophy type 3 patients during nusinersen therapy up to 34 
G. Musso   +12 more
wiley   +1 more source

Scientific Opinion on Flavouring Group Evaluation 73, Revision 4 (FGE.73Rev4): consideration of alicyclic alcohols, aldehydes, acids and related esters evaluated by JECFA (59th and 63rd meeting) structurally related to primary saturated or unsaturated alicyclic alcohols, aldehydes, acids and esters evaluated by EFSA in FGE.12Rev5. [PDF]

open access: yesEFSA J, 2017
EFSA CEF Panel (EFSA Panel on Food Contact Materials   +30 more
europepmc   +1 more source

THE SOCIETY OF BRITISH NEUROLOGICAL SURGEONS: 63rd MEETING [PDF]

open access: yesJournal of Neurology, Neurosurgery & Psychiatry, 1961
openaire   +1 more source

Home - About - Disclaimer - Privacy